The SPTBN1 gene inhibits processes such as epithelial–mesenchymal transition (EMT), proliferation, and metastasis of cancer cells, which are associated with lower survival rates and unfavorable prognosis in BC patients [12]. This evidence concerns the gene SPTBN1 and cancer.